RNA therapies: Wurzburg nanotransporters against heart attacks
April 21, 2026
April 21, 2026
WURZBURG, Germany, April 21 -- The University of Wurzburg issued the following news release:
* * *
RNA therapies: Wurzburg nanotransporters against heart attacks
They are the most common cause of death worldwide: cardiovascular diseases. Despite this, there has only been limited progress in their research and treatment in recent decades. A research project involving the University of Wurzburg (JMU) called "curATime" now aims to change this. This i . . .
* * *
RNA therapies: Wurzburg nanotransporters against heart attacks
They are the most common cause of death worldwide: cardiovascular diseases. Despite this, there has only been limited progress in their research and treatment in recent decades. A research project involving the University of Wurzburg (JMU) called "curATime" now aims to change this. This i . . .
